OBJECTIVE: To evaluate the effectiveness of peripheral angioplasty (PTA) as the first-choice revascularisation procedure in diabetic patients with critical limb ischemia (CLI). DESIGN: Prospective study. METHODS: PTA was employed as first choice revascularisation in a consecutive series of diabetic patients hospitalized for CLI between January 1999 and December 2003. RESULTS: PTA was successful performed in 993 patients. Seventeen (1.7%) major amputations were carried out. One death and 33 non-fatal complications were observed. Mean follow-up was 26+/-15 months. Clinical restenosis was observed in 87 patients. The 5 years primary patency was 88%, 95% CI 86-91%. During follow-up 119 (12.0%) patients died at a rate of 6.7% per year. CONCLUSIONS: PTA as the first choice revascularisation procedure is feasible, safe and effective for limb salvage in a high percentage of diabetic patients. Clinical restenosis was an infrequent event and PTA could successfully be repeated in most cases.
OBJECTIVE: To evaluate the effectiveness of peripheral angioplasty (PTA) as the first-choice revascularisation procedure in diabeticpatients with critical limb ischemia (CLI). DESIGN: Prospective study. METHODS:PTA was employed as first choice revascularisation in a consecutive series of diabeticpatients hospitalized for CLI between January 1999 and December 2003. RESULTS:PTA was successful performed in 993 patients. Seventeen (1.7%) major amputations were carried out. One death and 33 non-fatal complications were observed. Mean follow-up was 26+/-15 months. Clinical restenosis was observed in 87 patients. The 5 years primary patency was 88%, 95% CI 86-91%. During follow-up 119 (12.0%) patients died at a rate of 6.7% per year. CONCLUSIONS:PTA as the first choice revascularisation procedure is feasible, safe and effective for limb salvage in a high percentage of diabeticpatients. Clinical restenosis was an infrequent event and PTA could successfully be repeated in most cases.
Authors: Manuel Pardo; Miguel Alcaraz; Fernando Luis Bernal; Jose Manuel Felices; Gyingriri Daniel Achel; Francisco Ramon Breijo-Marquez; Manuel Canteras Journal: Radiol Med Date: 2013-05-27 Impact factor: 3.469